EHC 2016 Annual Conference Evaluation

Question Title

* 1. How would you rate overall:

	Very poor	Poor	Average	Good	Excellent
The EHC Conference (generally)	The EHC Conference (generally) Very poor	The EHC Conference (generally) Poor	The EHC Conference (generally) Average	The EHC Conference (generally) Good	The EHC Conference (generally) Excellent
Scientific programme, content and speakers	Scientific programme, content and speakers Very poor	Scientific programme, content and speakers Poor	Scientific programme, content and speakers Average	Scientific programme, content and speakers Good	Scientific programme, content and speakers Excellent
Exhibition stands	Exhibition stands Very poor	Exhibition stands Poor	Exhibition stands Average	Exhibition stands Good	Exhibition stands Excellent
Posters	Posters Very poor	Posters Poor	Posters Average	Posters Good	Posters Excellent
Film and Blog area	Film and Blog area Very poor	Film and Blog area Poor	Film and Blog area Average	Film and Blog area Good	Film and Blog area Excellent
Symposia (generally)	Symposia (generally) Very poor	Symposia (generally) Poor	Symposia (generally) Average	Symposia (generally) Good	Symposia (generally) Excellent
Conference organisation (logistics and communication)	Conference organisation (logistics and communication) Very poor	Conference organisation (logistics and communication) Poor	Conference organisation (logistics and communication) Average	Conference organisation (logistics and communication) Good	Conference organisation (logistics and communication) Excellent
Venue and facilities	Venue and facilities Very poor	Venue and facilities Poor	Venue and facilities Average	Venue and facilities Good	Venue and facilities Excellent
Food and refreshments	Food and refreshments Very poor	Food and refreshments Poor	Food and refreshments Average	Food and refreshments Good	Food and refreshments Excellent

Question Title

* 2. Please rate the Friday session on 'Haemophilia Care in Norway'

	Very poor	Poor	Average	Good	Excellent
Delivery of haemophilia care in Norway – Prof Pål Andre Holme	Delivery of haemophilia care in Norway – Prof Pål Andre Holme Very poor	Delivery of haemophilia care in Norway – Prof Pål Andre Holme Poor	Delivery of haemophilia care in Norway – Prof Pål Andre Holme Average	Delivery of haemophilia care in Norway – Prof Pål Andre Holme Good	Delivery of haemophilia care in Norway – Prof Pål Andre Holme Excellent
Delivery of haemophilia care in other Nordic countries – Prof Jan Astermark	Delivery of haemophilia care in other Nordic countries – Prof Jan Astermark Very poor	Delivery of haemophilia care in other Nordic countries – Prof Jan Astermark Poor	Delivery of haemophilia care in other Nordic countries – Prof Jan Astermark Average	Delivery of haemophilia care in other Nordic countries – Prof Jan Astermark Good	Delivery of haemophilia care in other Nordic countries – Prof Jan Astermark Excellent
The relevance of information supplied	The relevance of information supplied Very poor	The relevance of information supplied Poor	The relevance of information supplied Average	The relevance of information supplied Good	The relevance of information supplied Excellent
The overall session	The overall session Very poor	The overall session Poor	The overall session Average	The overall session Good	The overall session Excellent

Any other comments on this session?

Question Title

* 3. Please rate the Friday session on 'Update on dental care and von Willebrand treatment'

	Very poor	Poor	Average	Good	Excellent
Update on von Willebrand Treatment – Prof Mike Laffan	Update on von Willebrand Treatment – Prof Mike Laffan Very poor	Update on von Willebrand Treatment – Prof Mike Laffan Poor	Update on von Willebrand Treatment – Prof Mike Laffan Average	Update on von Willebrand Treatment – Prof Mike Laffan Good	Update on von Willebrand Treatment – Prof Mike Laffan Excellent
Dental Care – Dr Alison Dougall	Dental Care – Dr Alison Dougall Very poor	Dental Care – Dr Alison Dougall Poor	Dental Care – Dr Alison Dougall Average	Dental Care – Dr Alison Dougall Good	Dental Care – Dr Alison Dougall Excellent
The relevance of information supplied	The relevance of information supplied Very poor	The relevance of information supplied Poor	The relevance of information supplied Average	The relevance of information supplied Good	The relevance of information supplied Excellent
The overall session	The overall session Very poor	The overall session Poor	The overall session Average	The overall session Good	The overall session Excellent

Any other comments on this session?

Question Title

* 4. Please rate the Saturday session on 'New Developments in Haemophilia Care'

	Very poor	Poor	Average	Good	Excellent
Gene Therapy – Prof Edward Tuddenham	Gene Therapy – Prof Edward Tuddenham Very poor	Gene Therapy – Prof Edward Tuddenham Poor	Gene Therapy – Prof Edward Tuddenham Average	Gene Therapy – Prof Edward Tuddenham Good	Gene Therapy – Prof Edward Tuddenham Excellent
Bi- Specific antibody, antithrombin and other new developments – Prof Johannes Oldenburg	Bi- Specific antibody, antithrombin and other new developments – Prof Johannes Oldenburg Very poor	Bi- Specific antibody, antithrombin and other new developments – Prof Johannes Oldenburg Poor	Bi- Specific antibody, antithrombin and other new developments – Prof Johannes Oldenburg Average	Bi- Specific antibody, antithrombin and other new developments – Prof Johannes Oldenburg Good	Bi- Specific antibody, antithrombin and other new developments – Prof Johannes Oldenburg Excellent
EAHAD perspective – Prof Cedric Hermans	EAHAD perspective – Prof Cedric Hermans Very poor	EAHAD perspective – Prof Cedric Hermans Poor	EAHAD perspective – Prof Cedric Hermans Average	EAHAD perspective – Prof Cedric Hermans Good	EAHAD perspective – Prof Cedric Hermans Excellent
The relevance of information supplied	The relevance of information supplied Very poor	The relevance of information supplied Poor	The relevance of information supplied Average	The relevance of information supplied Good	The relevance of information supplied Excellent
The overall session	The overall session Very poor	The overall session Poor	The overall session Average	The overall session Good	The overall session Excellent

Any other comments on this session?

Question Title

* 5. Please rate the Saturday session on 'Inhibitors'

	Very poor	Poor	Average	Good	Excellent
Inhibitors in previously untreated patients – Prof Flora Peyvandi	Inhibitors in previously untreated patients – Prof Flora Peyvandi Very poor	Inhibitors in previously untreated patients – Prof Flora Peyvandi Poor	Inhibitors in previously untreated patients – Prof Flora Peyvandi Average	Inhibitors in previously untreated patients – Prof Flora Peyvandi Good	Inhibitors in previously untreated patients – Prof Flora Peyvandi Excellent
Mild Haemophilia – Prof Paul Giangrande	Mild Haemophilia – Prof Paul Giangrande Very poor	Mild Haemophilia – Prof Paul Giangrande Poor	Mild Haemophilia – Prof Paul Giangrande Average	Mild Haemophilia – Prof Paul Giangrande Good	Mild Haemophilia – Prof Paul Giangrande Excellent
Acquired haemophilia – Dr Laszlo Nemes	Acquired haemophilia – Dr Laszlo Nemes Very poor	Acquired haemophilia – Dr Laszlo Nemes Poor	Acquired haemophilia – Dr Laszlo Nemes Average	Acquired haemophilia – Dr Laszlo Nemes Good	Acquired haemophilia – Dr Laszlo Nemes Excellent
Panel discussions	Panel discussions Very poor	Panel discussions Poor	Panel discussions Average	Panel discussions Good	Panel discussions Excellent
The relevance of information supplied	The relevance of information supplied Very poor	The relevance of information supplied Poor	The relevance of information supplied Average	The relevance of information supplied Good	The relevance of information supplied Excellent
The overall session	The overall session Very poor	The overall session Poor	The overall session Average	The overall session Good	The overall session Excellent

Any other comments on this session?

Question Title

* 6. Please rate the Sunday session on 'Clinical Debates'

	Very poor	Poor	Average	Good	Excellent
Gene therapy – a cure in 10 years, yes or no? – Prof Edward Tuddenham, Prof Michael Makris	Gene therapy – a cure in 10 years, yes or no? – Prof Edward Tuddenham, Prof Michael Makris Very poor	Gene therapy – a cure in 10 years, yes or no? – Prof Edward Tuddenham, Prof Michael Makris Poor	Gene therapy – a cure in 10 years, yes or no? – Prof Edward Tuddenham, Prof Michael Makris Average	Gene therapy – a cure in 10 years, yes or no? – Prof Edward Tuddenham, Prof Michael Makris Good	Gene therapy – a cure in 10 years, yes or no? – Prof Edward Tuddenham, Prof Michael Makris Excellent
Extended half-life factors will be the standard of care, yes or no? – Dr Angelika Batorova, Prof Paul Giangrande	Extended half-life factors will be the standard of care, yes or no? – Dr Angelika Batorova, Prof Paul Giangrande Very poor	Extended half-life factors will be the standard of care, yes or no? – Dr Angelika Batorova, Prof Paul Giangrande Poor	Extended half-life factors will be the standard of care, yes or no? – Dr Angelika Batorova, Prof Paul Giangrande Average	Extended half-life factors will be the standard of care, yes or no? – Dr Angelika Batorova, Prof Paul Giangrande Good	Extended half-life factors will be the standard of care, yes or no? – Dr Angelika Batorova, Prof Paul Giangrande Excellent
Caesarian sections for carriers, yes or no? – Prof Rezan Khadir, Dr Danijela Mikovic	Caesarian sections for carriers, yes or no? – Prof Rezan Khadir, Dr Danijela Mikovic Very poor	Caesarian sections for carriers, yes or no? – Prof Rezan Khadir, Dr Danijela Mikovic Poor	Caesarian sections for carriers, yes or no? – Prof Rezan Khadir, Dr Danijela Mikovic Average	Caesarian sections for carriers, yes or no? – Prof Rezan Khadir, Dr Danijela Mikovic Good	Caesarian sections for carriers, yes or no? – Prof Rezan Khadir, Dr Danijela Mikovic Excellent
The relevance of information supplied	The relevance of information supplied Very poor	The relevance of information supplied Poor	The relevance of information supplied Average	The relevance of information supplied Good	The relevance of information supplied Excellent
The overall session	The overall session Very poor	The overall session Poor	The overall session Average	The overall session Good	The overall session Excellent

Any other comments on this session?

Question Title

* 7. Please rate the Sunday session on 'Patient – Reported Outcome Data'

	Very poor	Poor	Average	Good	Excellent
Haemophilia in Europe in 2016- results of the EHC Survey – Mr. Brian O’Mahony	Haemophilia in Europe in 2016- results of the EHC Survey – Mr. Brian O’Mahony Very poor	Haemophilia in Europe in 2016- results of the EHC Survey – Mr. Brian O’Mahony Poor	Haemophilia in Europe in 2016- results of the EHC Survey – Mr. Brian O’Mahony Average	Haemophilia in Europe in 2016- results of the EHC Survey – Mr. Brian O’Mahony Good	Haemophilia in Europe in 2016- results of the EHC Survey – Mr. Brian O’Mahony Excellent
Update on the CHESS project – Mr. Jamie O’Hara	Update on the CHESS project – Mr. Jamie O’Hara Very poor	Update on the CHESS project – Mr. Jamie O’Hara Poor	Update on the CHESS project – Mr. Jamie O’Hara Average	Update on the CHESS project – Mr. Jamie O’Hara Good	Update on the CHESS project – Mr. Jamie O’Hara Excellent
Update on the PROBE survey data – Mr. Mark Skinner	Update on the PROBE survey data – Mr. Mark Skinner Very poor	Update on the PROBE survey data – Mr. Mark Skinner Poor	Update on the PROBE survey data – Mr. Mark Skinner Average	Update on the PROBE survey data – Mr. Mark Skinner Good	Update on the PROBE survey data – Mr. Mark Skinner Excellent
National registries – Dr Anneliese Hilger	National registries – Dr Anneliese Hilger Very poor	National registries – Dr Anneliese Hilger Poor	National registries – Dr Anneliese Hilger Average	National registries – Dr Anneliese Hilger Good	National registries – Dr Anneliese Hilger Excellent
The relevance of information supplied	The relevance of information supplied Very poor	The relevance of information supplied Poor	The relevance of information supplied Average	The relevance of information supplied Good	The relevance of information supplied Excellent
The overall session	The overall session Very poor	The overall session Poor	The overall session Average	The overall session Good	The overall session Excellent

Any other comments on this session?

Question Title

* 8. Did the EHC Conference fulfil your expectations?

Yes

No

Question Title

* 9. Do you plan to attend the 2017 EHC Conference in Vilnius?

Yes

No

Question Title

* 10. What should the EHC consider for the programme in the future?

Question Title

* 11. What could the EHC do better or differently in the future?

Question Title

* 12. Any other comments / suggestions / feedback?